Skip to Content

TV 2133 (Minocycline Hydrochloride Extended-Release 115 mg)

Pill with imprint TV 2133 is Green, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 115 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 115 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 2133

Minocycline hydrochloride extended-release 115 mg TV 2133

Minocycline Hydrochloride Extended-Release

TV 2133
115 mg
16.00 mm
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
carnauba wax, silicon dioxide, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 3350, polyethylene glycol 4000, titanium dioxide, triacetin, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.